Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
The Lancet · 1998
Cited by 8,265 works. doi:10.1016/s0140-6736(98)07037-8
References
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
- U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease
- UK prospective diabetes study (UKPDS)
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
- Metformin
- UK PROSPECTIVE DIABETES STUDY (UKPDS) .11. BIOCHEMICAL RISK-FACTORS IN TYPE-2 DIABETIC-PATIENTS AT DIAGNOSIS COMPARED WITH AGE-MATCHED NORMAL SUBJECTS
- United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus
- UK Prospective Diabetes Study (UKPDS) XI: Biochemical Risk Factors in Type 2 Diabetic Patients at Diagnosis Compared with Age‐matched Normal Subjects
- Biguanides and NIDDM
- UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 Diabetes